Skip to content
  • Careers
  • News & Events

Acurian Patient Engagement Services

  • Services
    • Patient Enrollment
    • Patient Retention
  • Experience
    • Cardiovascular
    • CNS
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • Men’s Health
    • Musculoskeletal
    • Oncology
    • Pain
    • Respiratory
    • Urology
    • Women’s Health
  • Methodology
  • Results
  • Contact Us
  • Services
    • Patient Enrollment
    • Patient Retention
  • Experience
    • Cardiovascular
    • CNS
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • Men’s Health
    • Musculoskeletal
    • Oncology
    • Pain
    • Respiratory
    • Urology
    • Women’s Health
  • Methodology
  • Results
  • Contact Us
  • Careers
  • News & Events

Privacy Policy Translations

Home / Privacy Policy / Privacy Policy Translations

Please click on the links below for the translated policy.

Czech Republic
Denmark
Dutch
French
French Canadian
German
Hebrew
Hungary
Italy
Japan
Mexico (US Spanish)
Polish
Portuguese
Spain
Swedish

Did you know?

Major depressive disorder (MDD) trials have traditionally experienced low First Office Visit and Consent rates (FOV 20%, Consent 60%).  

Now that you know more about us, let’s help you achieve enrollment certainty, save you money and accelerate your race to market. Talk to us today about how our patients-first approach can help your current or next clinical trial.

Contact Us »
  • Home
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • LinkedIn

© 2019 Accelerated Enrollment Solutions (AES)

TRUSTe